AJR ARRS: Your Link to CME
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
QUICK SEARCH:   [advanced]


     

This Article
Right arrow Figures Only
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow reprints & permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by van Westreenen, H. L.
Right arrow Articles by Jager, P. L.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by van Westreenen, H. L.
Right arrow Articles by Jager, P. L.
Social Bookmarking
Add to CiteULike   Add to Complore   Add to Connotea   Add to Del.icio.us   Add to Digg   Add to Reddit   Add to Technorati  
What's this?
Hotlight (NEW!)
Right arrow
What's Hotlight?
AJR 2005; 185:436-440
© American Roentgen Ray Society

Clinical Observations

Prognostic Value of the Standardized Uptake Value in Esophageal Cancer

Henderik L. van Westreenen1, John T. M. Plukker1, David C. P. Cobben1, Carolien J. M. Verhoogt2, Henk Groen3 and Pieter L. Jager2

1 Department of Surgery, University Hospital Groningen, Hanzeplein 1, PO Box 30001, 9700 RB Groningen, The Netherlands.
2 PET-Center, University Hospital Groningen, Groningen, The Netherlands.
3 Office for Medical Technology Assessment, University Hospital Groningen, Groningen, The Netherlands.

Abstract

OBJECTIVE. On PET, the level of tissue glycolysis can be quantified by the accumulation of fluorine-18-fluorodeoxyglucose expressed as the standardized uptake value (SUV). The aims of this study were to investigate the relation between SUV and the stage of disease and whether SUV can be used to predict resectability and survival in patients with esophageal cancer.

CONCLUSION. SUV can be used to predict resectability; however, SUV is not an independent factor that can be used to assess survival in patients with esophageal cancer.


Add to CiteULike CiteULike   Add to Complore Complore   Add to Connotea Connotea   Add to Del.icio.us Del.icio.us   Add to Digg Digg   Add to Reddit Reddit   Add to Technorati Technorati    What's this?


This article has been cited by other articles:


Home page
 Clin. Cancer Res.Home page
Y. J. Lee, A. Cho, B. C. Cho, M. Yun, S. K. Kim, J. Chang, J. W. Moon, I. K. Park, H. J. Choi, and J.-H. Kim
High Tumor Metabolic Activity as Measured by Fluorodeoxyglucose Positron Emission Tomography Is Associated with Poor Prognosis in Limited and Extensive Stage Small-Cell Lung Cancer
Clin. Cancer Res., April 1, 2009; 15(7): 2426 - 2432.
[Abstract] [Full Text] [PDF]

Home page
 Clin. Cancer Res.Home page
W. A. Weber, J. Czernin, and M. E. Phelps
Prognostic Significance of Fluorodeoxyglucose Uptake in Non-Small Cell Lung Cancer. A Blurry Picture?
Clin. Cancer Res., June 1, 2007; 13(11): 3105 - 3106.
[Full Text] [PDF]

Home page
 Ann. Thorac. Surg.Home page
R. J. Cerfolio and A. S. Bryant
Maximum Standardized Uptake Values on Positron Emission Tomography of Esophageal Cancer Predicts Stage, Tumor Biology, and Survival
Ann. Thorac. Surg., August 1, 2006; 82(2): 391 - 395.
[Abstract] [Full Text] [PDF]

Home page
 Ann. Surg. Oncol.Home page
E. Bastiaannet, O. S. Hoekstra, W. J. G. Oyen, P. L. Jager, T. Wobbes, and H. J. Hoekstra
Level of Fluorodeoxyglucose Uptake Predicts Risk for Recurrence in Melanoma Patients Presenting With Lymph Node Metastases
Ann. Surg. Oncol., July 1, 2006; 13(7): 919 - 926.
[Abstract] [Full Text] [PDF]


HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Copyright © 2005 by the American Roentgen Ray Society.